Enanta Pharmaceuticals
ENTA
$12.47
Share price
-0.08%
Change (1 day)
-64.12%
Change (1 year)
Categories
EPS for Enanta Pharmaceuticals (ENTA)
EPS in 2023 (TTM): -$6.31
According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$6.31. In 2022 the company made an earnings per share (EPS) of -$5.82 a decrease over its 2021 EPS that were of -$4.98.
EPS history for Enanta Pharmaceuticals from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$6.31 | 8.42% |
| 2022 | -$5.82 | 16.87% |
| 2021 | -$4.98 | 72.92% |
| 2020 | -$2.88 | -267.44% |
| 2019 | $1.72 | -61.35% |
| 2018 | $4.45 | 147.22% |
| 2017 | $1.80 | -460% |
| 2016 | -$0.50 | -114.88% |
| 2015 | $3.36 | -23.81% |
| 2014 | $4.41 | -244.12% |
| 2013 | -$3.06 | 354.58% |
| 2012 | -$0.67 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -323.22% | 🇺🇸 USA |
 Novartis NVS | $3.74 | -159.27% | 🇨🇭 Switzerland |
 AbbVie ABBV | $3.68 | -158.33% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $13.09 | -307.45% | 🇺🇸 USA |
 Merck MRK | $1.82 | -128.87% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -162.92% | 🇺🇸 USA |